Alzheimer’s / dementia biomarkers

ADM Diagnostics, LLC — a joint venture of Predictek, Inc., and Abiant, Inc. — is developing an advanced set of imaging biomarkers for Alzheimer’s disease and related dementias. Our approach incorporates FDG-PET, structural MRI, and amyloid PET, and uses state-of-the-art machine learning techniques combined with proprietary resampling and classification schemes.